Eicosanoid signalling pathways in the development and progression of colorectal cancer: Novel approaches for prevention/intervention

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 363-385

  Cathcart, Mary Clare ^a   Lysaght, Joanne ^a   Pidgeon, Graham P ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Arachidonic acid; Colorectal cancer; Cyclooxygenase; Cytochrome P 450; Lipoxygenase

Indexed keywords

15 HYDROPEROXYARACHIDONIC ACID; 2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; ARACHIDONIC ACID; BAICALEIN; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; DOCEBENONE; EPOXYICOSATRIENOIC ACID; ETALOCIB; FISH OIL; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; L 161982; LEUKOTRIENE; LIPOXYGENASE; MM 886; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTANOID; RESVERATROL; TOCOPHEROL; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLITIS; COLORECTAL CANCER; DIET; HUMAN; IMMUNE RESPONSE; INTERVENTION STUDY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TEA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HUMANS; LIPOXYGENASE INHIBITORS; LIPOXYGENASES; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION;

EID: 83855165094     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9324-x     Document Type: Review

References (219)

1. W.H.O. (2005). Global action against cancer. (pp. 1-24). World Health Organisation and International Union Against Cancer.
2. M Cuendet JM Pezzuto 2000 The role of cyclooxygenase and lipoxygenase in cancer chemoprevention Drug Metabolism and Drug Interactions 17 1-4 109 157 11201293 1:CAS:528:DC%2BD3MXis1Ggug%3D%3D
3. DM Klurfeld AW Bull 1997 Fatty acids and colon cancer in experimental models. [Review] The American Journal of Clinical Nutrition 66 6 Suppl 1530S 1538S 9394711 1:CAS:528:DyaK2sXnslSku7w%3D
4. Greene, E. R., Huang, S., Serhan, C. N., & Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins & Other Lipid Mediators, Epub, doi: 10.1016/j.prostaglandins.2011.08.004.
5. WL Smith 1989 The eicosanoids and their biochemical mechanisms of action Biochemistry Journal 259 2 315 324 1:CAS:528:DyaL1MXktVSktLY%3D
6. AJ Dannenberg K Subbaramaiah 2003 Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 4 6 431 436 14706335 1:CAS:528:DC%2BD2cXitFKquw%3D%3D
7. ES Antonarakis EI Heath JR Walczak WG Nelson H Fedor AM De Marzo, et al. 2009 Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers Journal of Clinical Oncology 27 30 4986 4993 10.1200/JCO.2009.21.9410 19720908 1:CAS:528:DC%2BD1MXhsVCrsrzO
8. T Dragovich H Burris 3rd P Loehrer DD Von Hoff S Chow S Stratton, et al. 2008 Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial American Journal of Clinical Oncology 31 2 157 162 10.1097/COC.0b013e31815878c9 18391600 1:CAS:528:DC%2BD1cXltVGksLo%3D
9. A Jakobsen JP Mortensen C Bisgaard J Lindebjerg SR Rafaelsen VO Bendtsen 2008 A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial International Journal of Colorectal Disease 23 3 251 255 10.1007/s00384-007-0407-7 18064474
10. VA Papadimitrakopoulou WN William Jr AJ Dannenberg SM Lippman JJ Lee FG Ondrey, et al. 2008 Pilot randomized phase II study of celecoxib in oral premalignant lesions Clinical Cancer Research 14 7 2095 2101 10.1158/1078-0432.CCR-07-4024 18381950 1:CAS:528:DC%2BD1cXkt1aku7o%3D
11. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., et al. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. New England Journal of Medicine, 343(21), 1520-1528, 1522 p following 1528.
12. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan, et al. 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial The New England Journal of Medicine 352 11 1092 1102 15713943 1:CAS:528:DC%2BD2MXit1Kqu7o%3D
13. A Helin-Salmivaara A Virtanen R Vesalainen JM Gronroos T Klaukka JE Idanpaan-Heikkila, et al. 2006 NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland European Heart Journal 27 14 1657 1663 10.1093/eurheartj/ ehl053 16731535
14. PM Kearney C Baigent J Godwin H Halls JR Emberson C Patrono 2006 Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials BMJ 332 7553 1302 1308 10.1136/bmj.332.7553.1302 16740558 1:CAS:528:DC%2BD28XntVSrtb4%3D
15. SD Solomon JJ McMurray MA Pfeffer J Wittes R Fowler P Finn, et al. 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention The New England Journal of Medicine 352 11 1071 1080 15713944 1:CAS:528:DC%2BD2MXit1Kqur4%3D
16. VW Yang JM Shields SR Hamilton EW Spannhake WC Hubbard LM Hylind, et al. 1998 Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis Cancer Research 58 8 1750 1753 9563494 1:CAS:528:DyaK1cXisleru78%3D
17. Pidgeon, G. P., Lysaght, J., Krishnamoorthy, S., Reynolds, J. V., O'Byrne, K., Nie, D., et al. (2007). Lipoxygenase metabolism: roles in tumor progression and survival. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review]. Cancer and Metastasis Reviews, 26(3-4), 503-524, doi: 10.1007/s10555-007-9098-3.
18. D Panigrahy A Kaipainen ER Greene S Huang 2010 Cytochrome P450-derived eicosanoids: the neglected pathway in cancer Cancer and Metastasis Reviews 29 4 723 735 10.1007/s10555-010-9264-x 20941528 1:CAS:528:DC%2BC3cXhtlant7%2FJ
19. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
20. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. [Research Support, N.I.H., Extramural Review]. Cell, 144(5), 646-674, doi: 10.1016/j.cell.2011.02.013.
21. W.H.O. (2008). GLOBOCAN 2008 fast stats. (pp. 1-8). International Agency for Research on Cancer.
22. N Arber B Levin 2005 Chemoprevention of colorectal cancer: ready for routine use? Recent Results in Cancer Research 166 213 230 15648192 1:CAS:528:DC%2BD2MXos1WisQ%3D%3D
23. GA Doherty FE Murray 2009 Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age? Expert Opinion on Therapeutic Targets 13 2 209 218 10.1517/14728220802653631 19236238 1:CAS:528:DC%2BD1MXksF2nuw%3D%3D
24. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893-2917, doi: 10.1002/ijc.25516.
25. G Hawcroft PM Loadman A Belluzzi MA Hull 2010 Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells Neoplasia 12 8 618 627 20689756 1:CAS:528: DC%2BC3cXpvVClsr4%3D
26. I Shureiqi SM Lippman 2001 Lipoxygenase modulation to reverse carcinogenesis Cancer Research 61 17 6307 6312 11522616 1:CAS:528: DC%2BD3MXmsF2jsrY%3D
27. SM Powell N Zilz Y Beazer-Barclay TM Bryan SR Hamilton SN Thibodeau, et al. 1992 APC mutations occur early during colorectal tumorigenesis Nature 359 6392 235 237 1528264 1:CAS:528:DyaK38XlvV2htbY%3D
28. AJ Smith HS Stern M Penner K Hay A Mitri BV Bapat, et al. 1994 Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons Cancer Research 54 21 5527 5530 7923190 1:CAS:528:DyaK2cXmvFyitr8%3D
29. A Catalano A Procopio 2005 New aspects on the role of lipoxygenases in cancer progression Histology and Histopathology 20 3 969 975 15944947 1:CAS:528:DC%2BD2MXpsFKjtL8%3D
30. Wang, D., & Dubois, R. N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29(6), 781-788 doi: 10.1038/onc.2009.421.
31. B Vogelstein ER Fearon SR Hamilton SE Kern AC Preisinger M Leppert, et al. 1988 Genetic alterations during colorectal-tumor development The New England Journal of Medicine 319 9 525 532 10.1056/NEJM198809013190901 2841597 1:STN:280:DyaL1czgt1aqtQ%3D%3D
32. A Leslie FA Carey NR Pratt RJ Steele 2002 The colorectal adenoma-carcinoma sequence British Journal of Surgery 89 7 845 860 10.1046/j.1365-2168.2002.02120.x 12081733 1:STN:280:DC%2BD38zjvFCmtg%3D%3D
33. KM Sheehan F O'Connell A O'Grady RM Conroy MB Leader MF Byrne, et al. 2004 The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas European Journal of Gastroenterology and Hepatology 16 6 619 625 15167166 1:CAS:528: DC%2BD2cXksVKgsLs%3D
34. X de Leval T Dassesse JM Dogne D Waltregny A Bellahcene V Benoit, et al. 2006 Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents Journal of Pharmacology and Experimental Therapeutics 318 3 1057 1067 16720756
35. DC Zeldin 2001 Epoxygenase pathways of arachidonic acid metabolism. [Review] Journal of Biological Chemistry 276 39 36059 36062 10.1074/jbc. R100030200 11451964 1:CAS:528:DC%2BD3MXnt1yku7o%3D
36. Serhan, C. N. (2009). Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. [Research Support, N.I.H., Extramural Review]. Journal of Thrombosis and Haemostasis, 7(Suppl 1), 44-48, doi: 10.1111/j.1538-7836.2009.03396.x.
37. H Gao WJ Welch GF DiBona CS Wilcox 1997 Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats American Journal of Physiology 273 2 Pt 2 H734 H739 9277490 1:CAS:528:DyaK2sXls12lsrg%3D
38. P Needleman S Moncada S Bunting JR Vane M Hamberg B Samuelsson 1976 Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides Nature 261 5561 558 560 934294 1:CAS:528:DyaE28XltFymsbs%3D
39. JY Fu JL Masferrer K Seibert A Raz P Needleman 1990 The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes Journal of Biological Chemistry 265 28 16737 16740 2120205 1:CAS:528: DyaK3cXlvV2lsL0%3D
40. CD Funk 2001 Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 5548 1871 1875 11729303 1:CAS:528:DC%2BD3MXovFSqurw%3D
41. P Patrignani MR Panara A Greco O Fusco C Natoli S Iacobelli, et al. 1994 Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases Journal of Pharmacology and Experimental Therapeutics 271 3 1705 1712 7996488 1:CAS:528:DyaK2MXisleks70%3D
42. C Hoffmann 2000 COX-2 in brain and spinal cord implications for therapeutic use Current Medicinal Chemistry 7 11 1113 1120 11032961 1:CAS:528:DC%2BD3cXotFWrsr0%3D
43. RC Harris JA McKanna Y Akai HR Jacobson RN Dubois MD Breyer 1994 Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction The Journal of Clinical Investigation 94 6 2504 2510 7989609 1:CAS:528:DyaK2MXisFWgsrk%3D
44. BM Forman J Chen RM Evans 1997 Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proceedings of the National Academy of Sciences of the United States of America 94 9 4312 4317 9113986 1:CAS:528:DyaK2sXjtVyhsbs%3D
45. SA Kliewer SS Sundseth SA Jones PJ Brown GB Wisely CS Koble, et al. 1997 Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma Proceedings of the National Academy of Sciences of the United States of America 94 9 4318 4323 9113987 1:CAS:528:DyaK2sXjtVyht7w%3D
46. RA Gupta J Tan WF Krause M Geraci TM Willson SK Dey 2000 Prostacyclin mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 97 13275 13280 11087869 1:CAS:528:DC%2BD3cXosVOjsr8%3D
47. D Wang H Wang Q Shi S Katkuri W Walhi B Desvergne, et al. 2004 Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta Cancer Cell 6 3 285 295 10.1016/j.ccr.2004.08.011 15380519 1:CAS:528:DC%2BD2cXot1KisL4%3D
48. D Wang RN Dubois 2010 Eicosanoids and cancer Nature Reviews. Cancer 10 3 181 193 10.1038/nrc2809 20168319 1:CAS:528:DC%2BC3cXitFemsbs%3D
49. E Ricciotti GA FitzGerald 2011 Prostaglandins and inflammation Arteriosclerosis, Thrombosis, and Vascular Biology 31 5 986 1000 10.1161/ATVBAHA.110.207449 21508345 1:CAS:528:DC%2BC3MXkvFantbs%3D
50. Funk, C. D. (1993). Molecular biology in the eicosanoid field. [Research Support, U.S. Gov't, P.H.S. Review]. Progress in Nucleic Acid Research & Molecular Biology, 45, 67-98.
51. Fabre, J. E., Goulet, J. L., Riche, E., Nguyen, M., Coggins, K., Offenbacher, S., et al. (2002). Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Journal of Clinical Investigation, 109(10), 1373-1380, doi: 10.1172/JCI14869.
52. Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. [Research Support, U.S. Gov't, P.H.S.]. Journal of Biological Chemistry, 271(7), 3460-3468.
53. B Rigas IS Goldman L Levine 1993 Altered eicosanoid levels in human colon cancer The Journal of Laboratory and Clinical Medicine 122 5 518 523 8228569 1:STN:280:DyaK2c%2FksFWkug%3D%3D
54. M Mal PK Koh PY Cheah EC Chan 2011 Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer Rapid Communications in Mass Spectrometry 25 6 755 764 10.1002/rcm.4926 21337637 1:CAS:528: DC%2BC3MXit1Ghtro%3D
55. MG Backlund JR Mann VR Holla FG Buchanan HH Tai ES Musiek, et al. 2005 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer Journal of Biological Chemistry 280 5 3217 3223 10.1074/jbc.M411221200 15542609 1:CAS:528:DC%2BD2MXovVCrug%3D%3D
56. MB Hansen-Petrik MF McEntee B Jull H Shi MB Zemel J Whelan 2002 Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice Cancer Research 62 2 403 408 11809688 1:CAS:528:DC%2BD38XhtVyhtr0%3D
57. T Kawamori N Uchiya T Sugimura K Wakabayashi 2003 Enhancement of colon carcinogenesis by prostaglandin E2 administration Carcinogenesis 24 5 985 990 12771044 1:CAS:528:DC%2BD3sXkt1WrsLY%3D
58. Y Hernandez J Sotolongo K Breglio D Conduah A Chen R Xu, et al. 2010 The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia BMC Gastroenterology 10 82 10.1186/1471-230X-10-82 20637112
59. M Nakanishi DC Montrose P Clark PR Nambiar GS Belinsky KP Claffey, et al. 2008 Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis Cancer Research 68 9 3251 3259 10.1158/0008-5472.CAN-07-6100 18451151 1:CAS:528:DC%2BD1cXltlSmu7c%3D
60. Nakanishi, M., Menoret, A., Tanaka, T., Miyamoto, S., Montrose, D. C., Vella, A., et al. (2011). Selective PGE2 suppression impairs colon carcinogenesis and modifies local mucosal immunity. Cancer Prevention Research (Philadelphia, Pa.). doi: 10.1158/1940-6207.CAPR-11-0188.
61. N Elander J Ungerback H Olsson S Uematsu S Akira P Soderkvist 2008 Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice Biochemical and Biophysical Research Communications 372 1 249 253 10.1016/j.bbrc.2008.05.026 18485889 1:CAS:528:DC%2BD1cXmvFekuro%3D
62. Sasaki, Y., Kamei, D., Ishikawa, Y., Ishii, T., Uematsu, S., Akira, S., et al. (2011). Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis. Oncogene. doi: 10.1038/onc.2011.472.
63. M Mutoh K Watanabe T Kitamura Y Shoji M Takahashi T Kawamori, et al. 2002 Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis Cancer Research 62 1 28 32 11782353 1:CAS:528:DC%2BD38XntlyqtA%3D%3D
64. K Watanabe T Kawamori S Nakatsugi T Ohta S Ohuchida H Yamamoto, et al. 1999 Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Research 59 20 5093 5096 10537280 1:CAS:528:DyaK1MXmvFelsrs%3D
65. T Kawamori T Kitamura K Watanabe N Uchiya T Maruyama S Narumiya, et al. 2005 Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development Carcinogenesis 26 2 353 357 10.1093/carcin/bgh322 15564292 1:CAS:528:DC%2BD2MXmsVykuw%3D%3D
66. SJ Myung RM Rerko M Yan P Platzer K Guda A Dotson, et al. 2006 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis Proceedings of the National Academy of Sciences of the United States of America 103 32 12098 12102 10.1073/pnas.0603235103 16880406 1:CAS:528:DC%2BD28Xotlyju7Y%3D
67. A Gustafsson E Hansson U Kressner S Nordgren M Andersson C Lonnroth, et al. 2007 Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression Acta Oncologica 46 8 1107 1112 10.1080/02841860701403061 17943472 1:CAS:528:DC%2BD2sXht1GrsrnK
68. RJ Bing M Miyataka KA Rich N Hanson X Wang HD Slosser, et al. 2001 Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer Clinical Cancer Research 7 11 3385 3392 11705852 1:CAS:528:DC%2BD3MXptFaju7c%3D
69. J Frigola M Munoz SJ Clark V Moreno G Capella MA Peinado 2005 Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy Oncogene 24 49 7320 7326 10.1038/sj.onc.1208883 16007128 1:CAS:528:DC%2BD2MXhtF2ns7%2FK
70. K Kabashima T Saji T Murata M Nagamachi T Matsuoka E Segi, et al. 2002 The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut The Journal of Clinical Investigation 109 7 883 893 10.1172/JCI14459 11927615 1:CAS:528:DC%2BD38Xis1Kju70%3D
71. O Galamb F Sipos S Spisak B Galamb T Krenacs G Valcz, et al. 2009 Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes Cellular Oncology 31 1 19 29 19096147 1:CAS:528:DC%2BD1cXhsFSmt7bP
72. JM Park Y Kanaoka N Eguchi K Aritake S Grujic AM Materi, et al. 2007 Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice Cancer Research 67 3 881 889 10.1158/0008-5472.CAN-05-3767 17283118 1:CAS:528:DC%2BD2sXht1yntLs%3D
73. SR Zamuner AW Bak PR Devchand JL Wallace 2005 Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2- derived prostaglandin d2 American Journal of Pathology 167 5 1293 1300 16251413 1:CAS:528:DC%2BD2MXht1agu7zK
74. D Wang RN DuBois 2008 Pro-inflammatory prostaglandins and progression of colorectal cancer Cancer Letters 267 2 197 203 10.1016/j.canlet.2008.03.004 18406516 1:CAS:528:DC%2BD1cXovF2hsLg%3D
75. JR Mann MG Backlund FG Buchanan T Daikoku VR Holla DW Rosenberg, et al. 2006 Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression Cancer Research 66 13 6649 6656 10.1158/0008-5472.CAN-06-1787 16818638 1:CAS:528: DC%2BD28XmsVamtbg%3D
76. H Sakai T Suzuki Y Takahashi M Ukai K Tauchi T Fujii, et al. 2006 Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2 FEBS Letters 580 14 3368 3374 16709411 1:CAS:528:DC%2BD28Xltlens70%3D
77. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 4 1183 1188 7926468 1:STN:280:DyaK2M%2FhtFamsA%3D%3D
78. MG Sciulli P Filabozzi S Tacconelli R Padovano E Ricciotti ML Capone, et al. 2005 Platelet activation in patients with colorectal cancer Prostaglandins, Leukotrienes, and Essential Fatty Acids 72 2 79 83 10.1016/j.plefa.2004.10.006 15626589 1:CAS:528:DC%2BD2MXjvFOi
79. D Wang RN Dubois 2008 Peroxisome proliferator-activated receptors and progression of colorectal cancer PPAR Research 2008 931074 10.1155/2008/931074 18551185
80. X Zuo Z Peng MJ Moussalli JS Morris RR Broaddus SM Fischer, et al. 2009 Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis Journal of the National Cancer Institute 101 10 762 767 10.1093/jnci/djp078 19436036 1:CAS:528:DC%2BD1MXmtlyit70%3D
81. D Wang H Wang Y Guo W Ning S Katkuri W Wahli, et al. 2006 Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression Proceedings of the National Academy of Sciences of the United States of America 103 50 19069 19074 10.1073/pnas.0607948103 17148604 1:CAS:528:DC%2BD28XhtlersrjN
82. AL Gonzalez RL Roberts PP Massion SJ Olson Y Shyr SB Shappell 2004 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation Human Pathology 35 7 840 849 15257547 1:CAS:528:DC%2BD2cXlslOqt7c%3D
83. I Shureiqi KJ Wojno JA Poore RG Reddy MJ Moussalli SA Spindler, et al. 1999 Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers Carcinogenesis 20 10 1985 1995 10506115 1:CAS:528:DyaK1MXmslGktbc%3D
84. V Subbarayan XC Xu J Kim P Yang A Hoque AL Sabichi, et al. 2005 Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia Neoplasia 7 3 280 293 10.1593/neo.04457 15799828 1:CAS:528:DC%2BD2MXjs1Krs7c%3D
85. DG Tang B Bhatia S Tang R Schneider-Broussard 2007 15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size) Prostaglandins & Other Lipid Mediators 82 1-4 135 146 10.1016/j.prostaglandins.2006.05.022 1:CAS:528:DC%2BD28Xht12ktL%2FL
86. X Chen S Wang N Wu S Sood P Wang Z Jin, et al. 2004 Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis Clinical Cancer Research 10 19 6703 6709 10.1158/1078-0432.CCR-04-0838 15475461 1:CAS:528:DC%2BD2cXot1Ohsr0%3D
87. X Gao DJ Grignon T Chbihi A Zacharek YQ Chen W Sakr, et al. 1995 Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer Urology 46 2 227 237 7624992 1:STN:280:DyaK2MzltV2jtA%3D%3D
88. S Gupta M Srivastava N Ahmad K Sakamoto DG Bostwick H Mukhtar 2001 Lipoxygenase-5 is overexpressed in prostate adenocarcinoma Cancer 91 4 737 743 10.1002/1097-0142(20010215)91:4<737 11241241 1:CAS:528:DC%2BD3MXhsFCrtLo%3D
89. WG Jiang A Douglas-Jones RE Mansel 2003 Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer Prostaglandins, Leukotrienes, and Essential Fatty Acids 69 4 275 281 12907138 1:CAS:528:DC%2BD3sXlvFOku7Y%3D
90. JF Ohd CK Nielsen J Campbell G Landberg H Lofberg A Sjolander 2003 Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas Gastroenterology 124 1 57 70 10.1053/gast.2003.50011 12512030 1:CAS:528:DC%2BD3sXot1antg%3D%3D
91. Shureiqi, I., Chen, D., Day, R. S., Zuo, X., Hochman, F. L., Ross, W. A., et al. (2010). Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Cancer Prevention Research (Philadelphia), 3(7), 829-838, doi: 10.1158/1940-6207.CAPR-09-0110.
92. Wasilewicz, M. P., Kolodziej, B., Bojulko, T., Kaczmarczyk, M., Sulzyc-Bielicka, V., Bielicki, D., et al. (2010). Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. [Research Support, Non-U.S. Gov't]. International Journal of Colorectal Disease, 25(9), 1079-1085, doi: 10.1007/s00384-010-0980-z.
93. LG Melstrom DJ Bentrem MR Salabat TJ Kennedy XZ Ding M Strouch, et al. 2008 Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model Clinical Cancer Research 14 20 6525 6530 10.1158/1078-0432.CCR-07-4631 18927292 1:CAS:528:DC%2BD1cXht1KgtbnF
94. Spector, A. A., Fang, X., Snyder, G. D., & Weintraub, N. L. (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. Progress in Lipid Research, 43(1), 55-90.
95. Jiang, J. G., Chen, C. L., Card, J. W., Yang, S., Chen, J. X., Fu, X. N., et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. [Research Support, Non-U.S. Gov't]. Cancer Research, 65(11), 4707-4715, doi: 10.1158/0008-5472.CAN-04-4173.
96. Jiang, J. G., Fu, X. N., Chen, C. L., & Wang, D. W. (2009). Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines. [Research Support, Non-U.S. Gov't]. Ai Zheng, 28(2), 93-96.
97. T Yoshida S Ohki M Kanazawa H Mizunuma Y Kikuchi H Satoh, et al. 1998 Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer Surgery Today 28 7 740 745 9697269 1:CAS:528:DyaK1cXlt1ejtro%3D
98. R Chinery RJ Coffey R Graves-Deal SC Kirkland SC Sanchez WE Zackert, et al. 1999 Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells Cancer Research 59 11 2739 2746 10364000 1:CAS:528:DyaK1MXjs1ymt7s%3D
99. D Wang FG Buchanan H Wang SK Dey RN DuBois 2005 Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade Cancer Research 65 5 1822 1829 10.1158/0008-5472.CAN-04-3671 15753380 1:CAS:528:DC%2BD2MXitVOjsbk%3D
100. R Pai B Soreghan IL Szabo M Pavelka D Baatar AS Tarnawski 2002 Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nature Medicine 8 3 289 293 11875501 1:CAS:528:DC%2BD38Xit1CitLk%3D
101. MD Castellone H Teramoto BO Williams KM Druey JS Gutkind 2005 Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 5753 1504 1510 10.1126/science.1116221 16293724 1:CAS:528:DC%2BD2MXht1GqsrvF
102. I Loffler M Grun FD Bohmer I Rubio 2008 Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2 BMC Cancer 8 380 10.1186/1471-2407-8-380 19099561
103. A Pozzi X Yan I Macias-Perez S Wei AN Hata RM Breyer, et al. 2004 Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation Journal of Biological Chemistry 279 28 29797 29804 10.1074/jbc.M313989200 15123663 1:CAS:528:DC%2BD2cXlsVCltbk%3D
104. DP Cherukuri XB Chen AC Goulet RN Young Y Han RL Heimark, et al. 2007 The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells Experimental Cell Research 313 14 2969 2979 10.1016/j.yexcr.2007.06.004 17631291 1:CAS:528:DC%2BD2sXosFyktLo%3D
105. SW Park HS Kim MS Choi WJ Jeong DS Heo KH Kim, et al. 2011 The effects of the stromal cell-derived cyclooxygenase-2 metabolite prostaglandin E2 on the proliferation of colon cancer cells Journal of Pharmacology and Experimental Therapeutics 336 2 516 523 10.1124/jpet.110.173278 21062968 1:CAS:528: DC%2BC3MXhslWhsLk%3D
106. D Xia VR Holla D Wang DG Menter RN DuBois 2010 HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells Cancer Research 70 2 824 831 10.1158/0008-5472.CAN-09-2105 20068165 1:CAS:528:DC%2BC3cXltlaisw%3D%3D
107. LN Kaliberova SA Kusmartsev V Krendelchtchikova CR Stockard WE Grizzle DJ Buchsbaum, et al. 2009 Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression Molecular Cancer Therapeutics 8 11 3130 3139 10.1158/1535-7163.MCT-09-0270 19887544 1:CAS:528:DC%2BD1MXhtlyrt7%2FF
108. Kim, S. H., Park, Y. Y., Kim, S. W., Lee, J. S., Wang, D., & Dubois, R. N. (2011). ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Research. doi: 10.1158/0008-5472.CAN-11-1262.
109. G Cassano G Gasparre F Susca C Lippe G Guanti 2000 Lack of effect by prostaglandin F2alpha on the proliferation of the HCT-8 and HT-29 human adenocarcinoma cell lines Oncology Reports 7 1 183 186 10601615 1:CAS:528:DC%2BD3cXjslKgsg%3D%3D
110. AR Brash 1999 Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate Journal of Biological Chemistry 274 34 23679 23682 10446122 1:CAS:528:DyaK1MXlsVOnsrc%3D
111. X Norel C Brink 2004 The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues Pharmacology and Therapeutics 103 1 81 94 10.1016/j.pharmthera.2004.05.003 15251228 1:CAS:528:DC%2BD2cXlsFyksr8%3D
112. A Ihara K Wada M Yoneda N Fujisawa H Takahashi A Nakajima 2007 Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer Journal of Pharmacological Sciences 103 1 24 32 17220595 1:CAS:528:DC%2BD2sXhvFGnurk%3D
113. YN Ye ES Liu VY Shin WK Wu CH Cho 2004 The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone Journal of Pharmacology and Experimental Therapeutics 311 1 123 130 10.1124/jpet.104.068031 15161935 1:CAS:528:DC%2BD2cXosVKrtro%3D
114. L Michalik B Desvergne W Wahli 2004 Peroxisome-proliferator-activated receptors and cancers: complex stories Nature Reviews. Cancer 4 1 61 70 10.1038/nrc1254 14708026 1:CAS:528:DC%2BD2cXos12mug%3D%3D
115. M Yoshinaga FG Buchanan RN DuBois 2004 15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells Prostaglandins & Other Lipid Mediators 73 1-2 111 122 1:CAS:528: DC%2BD2cXivVCqtL4%3D
116. GG Chen JF Lee SH Wang UP Chan PC Ip WY Lau 2002 Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer Life Sciences 70 22 2631 2646 12269390 1:CAS:528:DC%2BD38XkvVCitLg%3D
117. M Koyama Y Izutani AE Goda TA Matsui M Horinaka M Tomosugi, et al. 2010 Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis Clinical Cancer Research 16 8 2320 2332 10.1158/1078-0432.CCR-09-2301 20371690 1:CAS:528:DC%2BC3cXkslSmu7o%3D
118. MS Lin WC Chen X Bai YD Wang 2007 Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer Journal of Digestive Diseases 8 2 82 88 10.1111/j.1443-9573.2007.00290.x 17532820 1:CAS:528:DC%2BD2sXnsFSlsbs%3D
119. M Moriai N Tsuji D Kobayashi K Kuribayashi N Watanabe 2009 Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells International Journal of Oncology 34 5 1363 1372 19360348 1:CAS:528: DC%2BD1MXlsVejurg%3D
120. T Shimada K Kojima K Yoshiura H Hiraishi A Terano 2002 Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells Gut 50 5 658 664 11950812 1:CAS:528: DC%2BD38XjvFeks7o%3D
121. SW Shin CY Seo H Han JY Han JS Jeong JY Kwak, et al. 2009 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity Clinical Cancer Research 15 17 5414 5425 10.1158/1078-0432.CCR-08-3101 19690198 1:CAS:528:DC%2BD1MXhtVOntrjL
122. RY Su KH Chi DY Huang MH Tai WW Lin 2008 15-deoxy-Delta12,14- prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription Molecular Cancer Therapeutics 7 10 3429 3440 10.1158/1535-7163.MCT-08-0498 18852146 1:CAS:528:DC%2BD1cXht1ensbzE
123. L Wang W Chen X Xie Y He X Bai 2008 Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer Experimental Oncology 30 1 42 51 18438340
124. V Leone A di Palma P Ricchi F Acquaviva M Giannouli AM Di Prisco, et al. 2007 PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation American Journal of Physiology-Gastrointestinal and Liver Physiology 293 4 G673 G681 10.1152/ajpgi.00584.2006 17640974 1:CAS:528:DC%2BD2sXht1WrsbjN
125. J Kaur SN Sanyal 2010 PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac Tumour Biology 31 6 623 631 10.1007/s13277-010- 0078-9 20617408 1:CAS:528:DC%2BC3cXht1OmtrrJ
126. H Sheng J Shao JD Morrow RD Beauchamp RN DuBois 1998 Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Research 58 2 362 366 9443418 1:CAS:528:DyaK1cXnt1altQ%3D%3D
127. A Greenhough CA Wallam DJ Hicks M Moorghen AC Williams C Paraskeva 2010 The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells Oncogene 29 23 3398 3410 10.1038/onc.2010.94 20348947 1:CAS:528:DC%2BC3cXjvFarsb4%3D
128. Roberts, H. R., Smartt, H. J., Greenhough, A., Moore, A. E., Williams, A. C., & Paraskeva, C. (2011). Colon tumour cells increase PGE2 by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis. doi: 10.1093/carcin/bgr210.
129. KK Wu JY Liou 2009 Cyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta -> 14-3-3epsilon pathway Methods in Molecular Biology 512 295 307 10.1007/978-1-60327-530-9-16 19347284 1:CAS:528: DC%2BC3cXmt1yrtQ%3D%3D
130. NS Cutler R Graves-Deal BJ LaFleur Z Gao BM Boman RH Whitehead, et al. 2003 Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells Cancer Research 63 8 1748 1751 12702555 1:CAS:528:DC%2BD3sXivFynsr8%3D
131. CN Chen CT Sung MT Lin PH Lee KJ Chang 2001 Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma Annals of Surgery 233 2 183 188 11176123 1:STN:280:DC%2BD3M7ls1SntQ%3D%3D
132. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 6801 249 257 11001068 1:CAS:528:DC%2BD3cXmvVSls74%3D
133. G Bergers LE Benjamin 2003 Tumorigenesis and the angiogenic switch Nature Reviews. Cancer 3 6 401 410 10.1038/nrc1093 12778130 1:CAS:528: DC%2BD3sXktFOnsb8%3D
134. R Fukuda B Kelly GL Semenza 2003 Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1 Cancer Research 63 9 2330 2334 12727858 1:CAS:528:DC%2BD3sXjtlGmtLc%3D
135. H Seno M Oshima TO Ishikawa H Oshima K Takaku T Chiba, et al. 2002 Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps Cancer Research 62 2 506 511 11809702 1:CAS:528:DC%2BD38XhtVyht7k%3D
136. M Sonoshita K Takaku N Sasaki Y Sugimoto F Ushikubi S Narumiya, et al. 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice Nature Medicine 7 9 1048 1051 10.1038/nm0901-1048 11533709 1:CAS:528:DC%2BD3MXmvFOls7Y%3D
137. H Amano I Hayashi H Endo H Kitasato S Yamashina T Maruyama, et al. 2003 Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth The Journal of Experimental Medicine 197 2 221 232 12538661 1:CAS:528:DC%2BD3sXmt1Sjuw%3D%3D
138. D Wang H Wang J Brown T Daikoku W Ning Q Shi, et al. 2006 CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer The Journal of Experimental Medicine 203 4 941 951 10.1084/jem.20052124 16567391 1:CAS:528:DC%2BD28Xjsl2is7g%3D
139. P Pradono R Tazawa M Maemondo M Tanaka K Usui Y Saijo, et al. 2002 Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth Cancer Research 62 1 63 66 11782360 1:CAS:528:DC%2BD38XntV2jtg%3D%3D
140. R Grau MA Iniguez M Fresno 2004 Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism Cancer Research 64 15 5162 5171 10.1158/0008-5472.CAN-04-0849 15289320 1:CAS:528:DC%2BD2cXmtF2mtLg%3D
141. YN Ye WK Wu VY Shin CH Cho 2005 A mechanistic study of colon cancer growth promoted by cigarette smoke extract European Journal of Pharmacology 519 1-2 52 57 10.1016/j.ejphar.2005.07.009 16125168 1:CAS:528:DC%2BD2MXpslymsL8%3D
142. Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., et al. (2007). Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Prostaglandins & Other Lipid Mediators, 82(1-4), 162-174, doi: 10.1016/j.prostaglandins.2006.08.005.
143. MJ Bissell VM Weaver SA Lelievre F Wang OW Petersen KL Schmeichel 1999 Tissue structure, nuclear organization, and gene expression in normal and malignant breast Cancer Research 59 7 Suppl 1757s 1763s 1:CAS:528: DyaK1MXisVWrs7Y%3D discussion 1763s-1764s
144. FG Giancotti E Ruoslahti 1999 Integrin signaling Science 285 5430 1028 1032 10446041 1:CAS:528:DyaK1MXlt1Gns7o%3D
145. EA Clark JS Brugge 1995 Integrins and signal transduction pathways: the road taken Science 268 5208 233 239 7716514 1:CAS:528:DyaK2MXltVCitLk%3D
146. A Howe AE Aplin SK Alahari RL Juliano 1998 Integrin signaling and cell growth control Current Opinion in Cell Biology 10 2 220 231 9561846 1:CAS:528:DyaK1cXisFyntLs%3D
147. DP Felsenfeld D Choquet MP Sheetz 1996 Ligand binding regulates the directed movement of beta1 integrins on fibroblasts Nature 383 6599 438 440 10.1038/383438a0 8837776 1:CAS:528:DyaK28Xmt1yktbg%3D
148. Sheetz, M. P., Felsenfeld, D. P., & Galbraith, C. G. (1998). Cell migration: regulation of force on extracellular-matrix-integrin complexes. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. Trends in Cell Biology, 8(2), 51-54.
149. F Cianchi C Cortesini P Bechi O Fantappie L Messerini A Vannacci, et al. 2001 Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer Gastroenterology 121 6 1339 1347 11729113 1:CAS:528:DC%2BD38Xhs12htw%3D%3D
150. H Fujino K Toyomura XB Chen JW Regan T Murayama 2011 Prostaglandin E regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells Biochemical Pharmacology 81 3 379 387 10.1016/j.bcp.2010.11.001 21070749 1:CAS:528:DC%2BC3cXhs1ajtrvL
151. L Yang Y Huang R Porta K Yanagisawa A Gonzalez E Segi, et al. 2006 Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism Cancer Research 66 19 9665 9672 10.1158/0008-5472.CAN-06-1271 17018624 1:CAS:528:DC%2BD28XhtVams73P
152. FG Buchanan D Wang F Bargiacchi RN DuBois 2003 Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor Journal of Biological Chemistry 278 37 35451 35457 10.1074/jbc. M302474200 12824187 1:CAS:528:DC%2BD3sXntVajsrw%3D
153. FG Buchanan DL Gorden P Matta Q Shi LM Matrisian RN DuBois 2006 Role of beta-arrestin 1 in the metastatic progression of colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 103 5 1492 1497 10.1073/pnas.0510562103 16432186 1:CAS:528:DC%2BD28Xhs1Gns7c%3D
154. R Pai T Nakamura WS Moon AS Tarnawski 2003 Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors The FASEB Journal 17 12 1640 1647 10.1096/fj.02-1011com 12958170 1:CAS:528:DC%2BD3sXntlSrsb4%3D
155. KV Honn B Cicone A Skoff 1981 Prostacyclin: a potent antimetastatic agent Science 212 4500 1270 1272 7015512 1:CAS:528:DyaL3MXktlKjtr0%3D
156. N Yoshida T Yoshikawa S Nakagawa K Sakamoto Y Nakamura Y Naito, et al. 1999 Effect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cells Clinical and Experimental Immunology 117 3 430 434 10469043 1:CAS:528:DyaK1MXmtV2ku7o%3D
157. GW Daneker SA Lund SW Caughman CA Staley WC Wood 1996 Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression Clinical & Experimental Metastasis 14 3 230 238 1:CAS:528:DyaK28XkvFelsbk%3D
158. I Yokoyama S Hayashi T Kobayashi M Negita M Yasutomi K Uchida, et al. 1995 Prevention of experimental hepatic metastasis with thromboxane synthase inhibitor Research in Experimental Medicine (Berlin) 195 4 209 215 1:CAS:528:DyaK2MXptFOgtbw%3D
159. D Qualtrough A Kaidi S Chell HN Jabbour AC Williams C Paraskeva 2007 Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells International Journal of Cancer 121 4 734 740 10.1002/ijc.22755 1:CAS:528:DC%2BD2sXotleqtbg%3D
160. Koontongkaew, S., Monthanapisut, P., & Saensuk, T. (2010). Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression. [Research Support, Non-U.S. Gov't]. Prostaglandins & Other Lipid Mediators, 93(3-4), 100-108, doi: 10.1016/j.prostaglandins. 2010.07.002.
161. LA Feagins RF Souza SJ Spechler 2009 Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer Nature Reviews. Gastroenterology & Hepatology 6 5 297 305 10.1038/nrgastro.2009.44 1:CAS:528: DC%2BD1MXmsFWru7k%3D
162. FV Din E Theodoratou SM Farrington A Tenesa RA Barnetson R Cetnarskyj, et al. 2010 Effect of aspirin and NSAIDs on risk and survival from colorectal cancer Gut 59 12 1670 1679 10.1136/gut.2009.203000 20844293 1:CAS:528: DC%2BC3MXpvFei
163. Terzic, J., Grivennikov, S., Karin, E., & Karin, M. (2010). Inflammation and colon cancer. Gastroenterology, 138(6), 2101-2114 e2105, doi: 10.1053/j.gastro.2010.01.058
164. MM Bertagnolli CJ Eagle AG Zauber M Redston SD Solomon K Kim, et al. 2006 Celecoxib for the prevention of sporadic colorectal adenomas The New England Journal of Medicine 355 9 873 884 10.1056/NEJMoa061355 16943400 1:CAS:528:DC%2BD28XovFaju7Y%3D
165. F Baratelli Y Lin L Zhu SC Yang N Heuze-Vourc'h G Zeng, et al. 2005 Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells Journal of Immunology 175 3 1483 1490 1:CAS:528: DC%2BD2MXmtlWjtrc%3D
166. S Yaqub K Henjum M Mahic FL Jahnsen EM Aandahl BA Bjornbeth, et al. 2008 Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner Cancer Immunology, Immunotherapy 57 6 813 821 10.1007/s00262-007-0417-x 17962941 1:CAS:528:DC%2BD1cXjvFKmtbw%3D
167. Q Wang Y Takei O Kobayashi T Osada S Watanabe 2009 Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells Journal of Clinical Biochemistry & Nutrition 45 2 163 170 10.3164/jcbn.09-21 1:CAS:528:DC%2BD1MXhtlWrsbvK
168. AF Sheibanie JH Yen T Khayrullina F Emig M Zhang R Tuma, et al. 2007 The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-> IL-17 axis Journal of Immunology 178 12 8138 8147 1:CAS:528:DC%2BD2sXmtVKnsbg%3D
169. S Tanaka A Tatsuguchi S Futagami K Gudis K Wada T Seo, et al. 2006 Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma Gut 55 1 54 61 10.1136/gut.2004.059824 16085694 1:CAS:528:DC%2BD28Xnt1yqtw%3D%3D
170. X Qian J Zhang J Liu 2010 Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway Journal of Biological Chemistry 286 3 2111 2120 10.1074/jbc.M110.154971 21097507
171. EC Cheon K Khazaie MW Khan MJ Strouch SB Krantz J Phillips, et al. 2011 Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice Cancer Research 71 5 1627 1636 10.1158/0008-5472.CAN-10-1923 21216893 1:CAS:528:DC%2BC3MXisFCnsro%3D
172. S Ostrand-Rosenberg 2010 Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Cancer Immunology, Immunotherapy 59 10 1593 1600 10.1007/s00262-010-0855-8 20414655
173. Y Yudina L Parhamifar AM Bengtsson M Juhas A Sjolander 2008 Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells Prostaglandins, Leukotrienes, and Essential Fatty Acids 79 6 223 231 10.1016/j.plefa.2008.09.024 19042113 1:CAS:528: DC%2BD1cXhsVKrtLfK
174. NB Janakiram CV Rao 2009 Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer Current Molecular Medicine 9 5 565 579 19601807 1:CAS:528:DC%2BD1MXntVCjurs%3D
175. T Lawrence DA Willoughby DW Gilroy 2002 Anti-inflammatory lipid mediators and insights into the resolution of inflammation Nature Reviews Immunology 2 10 787 795 10.1038/nri915 12360216 1:CAS:528:DC%2BD38XnsVGqtr8%3D
176. MJ Mangino L Brounts B Harms C Heise 2006 Lipoxin biosynthesis in inflammatory bowel disease Prostaglandins & Other Lipid Mediators 79 1-2 84 92 10.1016/j.prostaglandins.2005.10.004 1:CAS:528:DC%2BD28XitVKnsrg%3D
177. B Zhang H Jia J Liu Z Yang T Jiang K Tang, et al. 2011 Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4 Journal of Immunology 185 12 7199 7206 10.4049/jimmunol.1001876
178. T Ishizuka J Cheng H Singh MD Vitto VL Manthati JR Falck, et al. 2008 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells Journal of Pharmacology and Experimental Therapeutics 324 1 103 110 10.1124/jpet.107.130336 17947496 1:CAS:528:DC%2BD1cXhsF2itw%3D%3D
179. KN Theken Y Deng MA Kannon TM Miller SM Poloyac CR Lee 2010 Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism Drug Metabolism and Disposition 39 1 22 29 10.1124/dmd.110.035287 20947618
180. S Norwood J Liao BD Hammock GY Yang 2010 Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis American Journal of Translational Research 2 4 447 457 20733953 1:CAS:528:DC%2BC3cXps1Gmtb8%3D
181. BB Davis JY Liu DJ Tancredi L Wang SI Simon BD Hammock, et al. 2011 The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment Biochemical and Biophysical Research Communications 410 3 494 500 10.1016/j.bbrc.2011.06.008 21683067 1:CAS:528:DC%2BC3MXoslCnsLo%3D
182. O Radmark B Samuelsson 2010 Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer Journal of Internal Medicine 268 1 5 14 10.1111/j.1365-2796.2010.02246.x 20497297 1:CAS:528: DC%2BC3cXpsFSntLw%3D
183. O Schroder Y Yudina A Sabirsh N Zahn JZ Haeggstrom J Stein 2006 15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells Journal of Lipid Research 47 5 1071 1080 10.1194/jlr.M600008-JLR200 16495511
184. T Arisato T Hashiguchi KP Sarker K Arimura M Asano K Matsuo, et al. 2003 Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region Journal of Thrombosis and Haemostasis 1 12 2589 2593 14675094 1:CAS:528:DC%2BD2cXktFOlsbY%3D
185. TO Daniel H Liu JD Morrow BC Crews LJ Marnett 1999 Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis Cancer Research 59 18 4574 4577 10493510 1:CAS:528:DyaK1MXmtVKksbk%3D
186. JS Rhee M Black U Schubert S Fischer E Morgenstern HP Hammes, et al. 2004 The functional role of blood platelet components in angiogenesis Thrombosis and Haemostasis 92 2 394 402 10.1267/THRO04080394 15269837 1:CAS:528: DC%2BD2cXmvVertb8%3D
187. RL Bick 2006 Cancer-associated thrombosis: focus on extended therapy with dalteparin Journal of Supportive Oncology 4 3 115 120 16553136 1:CAS:528:DC%2BD28XkslKrsr8%3D
188. KV Honn BF Sloane 1983 Prostacyclin, thromboxanes, and hematogenous metastasis Advances in Prostaglandin, Thromboxane, and Leukotriene Research 12 313 318 6221609 1:CAS:528:DyaL3sXhvFGkt7w%3D
189. HM Pinedo HM Verheul RJ D'Amato J Folkman 1998 Involvement of platelets in tumour angiogenesis? Lancet 352 9142 1775 1777 9848370 1:STN:280: DyaK1M%2FmtlWitA%3D%3D
190. C Boccaccio G Sabatino E Medico F Girolami A Follenzi G Reato, et al. 2005 The MET oncogene drives a genetic programme linking cancer to haemostasis Nature 434 7031 396 400 10.1038/nature03357 15772665 1:CAS:528: DC%2BD2MXit1yru78%3D
191. FR Rickles 2006 Mechanisms of cancer-induced thrombosis in cancer Pathophysiology of Haemostasis and Thrombosis 35 1-2 103 110 16855354
192. X de Leval V Benoit J Delarge F Julemont B Masereel B Pirotte, et al. 2003 Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation Prostaglandins, Leukotrienes, and Essential Fatty Acids 68 1 55 59 12538091
193. YN Ye WK Wu VY Shin IC Bruce BC Wong CH Cho 2005 Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke Carcinogenesis 26 4 827 834 10.1093/carcin/bgi012 15637091 1:CAS:528: DC%2BD2MXis1yjsLY%3D
194. R Hennig XZ Ding WG Tong RC Witt BD Jovanovic TE Adrian 2004 Effect of LY293111 in combination with gemcitabine in colonic cancer Cancer Letters 210 1 41 46 10.1016/j.canlet.2004.02.023 15172119 1:CAS:528:DC%2BD2cXksVCisLk%3D
195. P Galfi Z Neogrady A Amberger R Margreiter A Csordas 2005 Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid Cancer Detection and Prevention 29 3 276 285 10.1016/j.cdp.2004.12.001 15936596 1:CAS:528:DC%2BD2MXms1egsbs%3D
196. KM Anderson T Seed M Vos J Mulshine J Meng W Alrefai, et al. 1998 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death Prostate 37 3 161 173 10.1002/(SICI)1097-0045(19981101) 37:3<161 9792133 1:CAS:528:DyaK1cXntFSnu78%3D
197. I Avis A Martinez J Tauler E Zudaire A Mayburd R Abu-Ghazaleh, et al. 2005 Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition Cancer Research 65 10 4181 4190 10.1158/0008-5472.CAN- 04-3441 15899809 1:CAS:528:DC%2BD2MXktlSmtr0%3D
198. F Cianchi C Cortesini L Magnelli E Fanti L Papucci N Schiavone, et al. 2006 Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells Molecular Cancer Therapeutics 5 11 2716 2726 10.1158/1535-7163.MCT-06-0318 17121918 1:CAS:528:DC%2BD28Xht1els7nL
199. CP Caygill A Charlett MJ Hill 1996 Fat, fish, fish oil and cancer British Journal of Cancer 74 1 159 164 8679451 1:STN:280:DyaK283ns1entQ%3D%3D
200. MB Petrik MF McEntee CH Chiu J Whelan 2000 Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice Journal of Nutrition 130 5 1153 1158 10801912 1:CAS:528:DC%2BD3cXivFKntLs%3D
201. G Calviello F Di Nicuolo S Gragnoli E Piccioni S Serini N Maggiano, et al. 2004 n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway Carcinogenesis 25 12 2303 2310 10.1093/carcin/bgh265 15358633 1:CAS:528:DC%2BD2cXhtVCrsrrL
202. J Vanamala A Glagolenko P Yang RJ Carroll ME Murphy RA Newman, et al. 2008 Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3 Carcinogenesis 29 4 790 796 10.1093/carcin/bgm256 18024478 1:CAS:528:DC%2BD1cXktlOhur4%3D
203. M Bose X Hao J Ju A Husain S Park JD Lambert, et al. 2007 Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3- gallate and fish oil Journal of Agricultural and Food Chemistry 55 19 7695 7700 10.1021/jf071004r 17696481 1:CAS:528:DC%2BD2sXptFClsL0%3D
204. RC Mund N Pizato S Bonatto EA Nunes T Vicenzi R Tanhoffer, et al. 2007 Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation Prostaglandins, Leukotrienes, and Essential Fatty Acids 76 2 113 120 10.1016/j.plefa.2006.11.008 17234396 1:CAS:528:DC%2BD2sXhvVyisrg%3D
205. R Bartoli F Fernandez-Banares E Navarro E Castella J Mane M Alvarez, et al. 2000 Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis Gut 46 2 191 199 10644312 1:CAS:528:DC%2BD3cXhtFyrtb4%3D
206. E Terzuoli S Donnini A Giachetti MA Iniguez M Fresno G Melillo, et al. 2010 Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis Clinical Cancer Research 16 16 4207 4216 10.1158/1078-0432.CCR-10-0156 20682710 1:CAS:528:DC%2BC3cXhtVajs7rP
207. J Ju X Hao MJ Lee JD Lambert G Lu H Xiao, et al. 2009 A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice Cancer Prevention Research (Philadelphia, Pa.) 2 2 143 152 10.1158/1940-6207.CAPR-08- 0099 1:CAS:528:DC%2BC3cXptFKgtbY%3D
208. A Koeberle H Northoff O Werz 2009 Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1 Molecular Cancer Therapeutics 8 8 2348 2355 10.1158/1535-7163.MCT-09- 0290 19671757 1:CAS:528:DC%2BD1MXpvFCmsrY%3D
209. J Hong M Bose J Ju JH Ryu X Chen S Sang, et al. 2004 Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase Carcinogenesis 25 9 1671 1679 10.1093/carcin/bgh165 15073046 1:CAS:528:DC%2BD2cXntFaiurk%3D
210. CV Rao A Rivenson B Simi BS Reddy 1995 Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Research 55 2 259 266 7812955 1:CAS:528:DyaK2MXjtFyjs7Y%3D
211. S Lev-Ari L Strier D Kazanov L Madar-Shapiro H Dvory-Sobol I Pinchuk, et al. 2005 Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells Clinical Cancer Research 11 18 6738 6744 10.1158/1078-0432.CCR-05- 0171 16166455 1:CAS:528:DC%2BD2MXhtVShsb3J
212. RE Carroll RV Benya DK Turgeon S Vareed M Neuman L Rodriguez, et al. 2011 Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prevention Research (Philadelphia, Pa.) 4 3 354 364 10.1158/1940-6207. CAPR-10-0098 1:CAS:528:DC%2BC3MXktl2ltbs%3D
213. E Hazai Z Bikadi F Zsila SF Lockwood 2006 Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase Bioorganic & Medicinal Chemistry 14 20 6859 6867 10.1016/j.bmc.2006.06.045 1:CAS:528:DC%2BD28XptFSks7k%3D
214. W Bednar K Holzmann B Marian 2007 Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme Food and Chemical Toxicology 45 3 508 514 10.1016/j.fct.2006.08.013 17027136 1:CAS:528:DC%2BD2sXhtlaru7Y%3D
215. S Kuntz U Wenzel H Daniel 1999 Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines European Journal of Nutrition 38 3 133 142 10443335 1:CAS:528:DyaK1MXkvVClsL4%3D
216. GP Pidgeon M Kandouz A Meram KV Honn 2002 Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells Cancer Research 62 9 2721 2727 11980674 1:CAS:528:DC%2BD38XjtlGrtLo%3D
217. WG Tong XZ Ding TE Adrian 2002 The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells Biochemical and Biophysical Research Communications 296 4 942 948 12200139 1:CAS:528: DC%2BD38XmsV2ku7c%3D
218. BB Aggarwal A Bhardwaj RS Aggarwal NP Seeram S Shishodia Y Takada 2004 Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Research 24 5A 2783 2840 15517885 1:CAS:528:DC%2BD2cXhtVSjsLrK
219. J Ju Y Liu J Hong MT Huang AH Conney CS Yang 2003 Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model Nutrition and Cancer 46 2 172 178 10.1207/S15327914NC4602-10 14690793 1:CAS:528: DC%2BD2cXislSnsA%3D%3D